Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Apr 1;99(7):1585–1595. doi: 10.1172/JCI119321

Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.

M Marre 1, X Jeunemaitre 1, Y Gallois 1, M Rodier 1, G Chatellier 1, C Sert 1, L Dusselier 1, Z Kahal 1, L Chaillous 1, S Halimi 1, A Muller 1, H Sackmann 1, B Bauduceau 1, F Bled 1, P Passa 1, F Alhenc-Gelas 1
PMCID: PMC507978  PMID: 9120002

Abstract

Diabetic nephropathy is a glomerular disease due to uncontrolled diabetes and genetic factors. It can be caused by glomerular hypertension produced by capillary vasodilation, due to diabetes, against constitutional glomerular resistance. As angiotensin II increases glomerular pressure, we studied the relationship between genetic polymorphisms in the renin-angiotensin system-angiotensin I converting enzyme (ACE), angiotensinogen (AGT), and angiotensin II, subtype 1, receptor-and the renal involvement of insulin-dependent diabetic subjects with proliferative retinopathy: those exposed to the risk of nephropathy due to diabetes. Of 494 subjects recruited in 17 centers in France and Belgium (GENEDIAB Study), 157 (32%) had no nephropathy, 104 (21%) incipient (microalbuminuria), 126 (25 %) established (proteinuria), and 107 (22%) advanced (plasma creatinine > or = 150 micromol/liter or renal replacement therapy) nephropathy. The severity of renal involvement was associated with ACE insertion/deletion (I/D) polymorphism: chi2 for trend 5.135, P = 0.023; adjusted odds ratio attributable to the D allele 1.889 (95% CI 1.209-2.952, P = 0.0052). Renal involvement was not directly linked to other polymorphisms. However, ACE I-D and AGT M235T polymorphisms interacted significantly (P = 0.0166): in subjects with ACE ID and DD genotypes, renal involvement increased from the AGT MM to TT genotypes. Thus, genetic determinants that affect renal angiotensin II and kinin productions are risk factors for the progression of glomerular disease in uncontrolled insulin-dependent diabetic patients.

Full Text

The Full Text of this article is available as a PDF (310.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alhenc-Gelas F., Baussant T., Hubert C., Soubrier F., Corvol P. The angiotensin converting enzyme in the kidney. J Hypertens Suppl. 1989 Sep;7(7):S9–S14. doi: 10.1097/00004872-198909007-00003. [DOI] [PubMed] [Google Scholar]
  2. Badenhop R. F., Wang X. L., Wilcken D. E. Angiotensin-converting enzyme genotype in children and coronary events in their grandparents. Circulation. 1995 Mar 15;91(6):1655–1658. doi: 10.1161/01.cir.91.6.1655. [DOI] [PubMed] [Google Scholar]
  3. Ballermann B. J., Skorecki K. L., Brenner B. M. Reduced glomerular angiotensin II receptor density in early untreated diabetes mellitus in the rat. Am J Physiol. 1984 Jul;247(1 Pt 2):F110–F116. doi: 10.1152/ajprenal.1984.247.1.F110. [DOI] [PubMed] [Google Scholar]
  4. Blackburn H. Classification of the electrocardiogram for population studies: Minnesota Code. J Electrocardiol. 1969 Jul;2(3):305–310. doi: 10.1016/s0022-0736(69)80120-2. [DOI] [PubMed] [Google Scholar]
  5. Bonnardeaux A., Davies E., Jeunemaitre X., Féry I., Charru A., Clauser E., Tiret L., Cambien F., Corvol P., Soubrier F. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension. 1994 Jul;24(1):63–69. doi: 10.1161/01.hyp.24.1.63. [DOI] [PubMed] [Google Scholar]
  6. Borch-Johnsen K., Kreiner S. Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J (Clin Res Ed) 1987 Jun 27;294(6588):1651–1654. doi: 10.1136/bmj.294.6588.1651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Borch-Johnsen K., Nørgaard K., Hommel E., Mathiesen E. R., Jensen J. S., Deckert T., Parving H. H. Is diabetic nephropathy an inherited complication? Kidney Int. 1992 Apr;41(4):719–722. doi: 10.1038/ki.1992.112. [DOI] [PubMed] [Google Scholar]
  8. Bouhanick B., Berrut G., Chameau A. M., Hallar M., Bled F., Chevet B., Vergely J., Rohmer V., Fressinaud P., Marre M. Predictive value of testing random urine sample to detect microalbuminuria in diabetic subjects during outpatient visit. Diabete Metab. 1992 Jan-Feb;18(1):54–58. [PubMed] [Google Scholar]
  9. Brenner B. M. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int. 1983 Apr;23(4):647–655. doi: 10.1038/ki.1983.72. [DOI] [PubMed] [Google Scholar]
  10. Cambien F., Alhenc-Gelas F., Herbeth B., Andre J. L., Rakotovao R., Gonzales M. F., Allegrini J., Bloch C. Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study. Am J Hum Genet. 1988 Nov;43(5):774–780. [PMC free article] [PubMed] [Google Scholar]
  11. Cambien F., Poirier O., Lecerf L., Evans A., Cambou J. P., Arveiler D., Luc G., Bard J. M., Bara L., Ricard S. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992 Oct 15;359(6396):641–644. doi: 10.1038/359641a0. [DOI] [PubMed] [Google Scholar]
  12. Caulfield M., Lavender P., Farrall M., Munroe P., Lawson M., Turner P., Clark A. J. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med. 1994 Jun 9;330(23):1629–1633. doi: 10.1056/NEJM199406093302301. [DOI] [PubMed] [Google Scholar]
  13. Chase H. P., Garg S. K., Marshall G., Berg C. L., Harris S., Jackson W. E., Hamman R. E. Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes. JAMA. 1991 Feb 6;265(5):614–617. [PubMed] [Google Scholar]
  14. Christlieb A. R., Janka H. U., Kraus B., Gleason R. E., Icasas-Cabral E. A., Aiello L. M., Cabral B. V., Solano A. Vascular reactivity to angiotensin II and to norepinephrine in diabetic subjects. Diabetes. 1976 Apr;25(4):268–274. doi: 10.2337/diab.25.4.268. [DOI] [PubMed] [Google Scholar]
  15. Costerousse O., Allegrini J., Lopez M., Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J. 1993 Feb 15;290(Pt 1):33–40. doi: 10.1042/bj2900033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Doi Y., Yoshizumi H., Yoshinari M., Iino K., Yamamoto M., Ichikawa K., Iwase M., Fujishima M. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia. 1996 Jan;39(1):97–102. doi: 10.1007/BF00400419. [DOI] [PubMed] [Google Scholar]
  17. Doria A., Onuma T., Gearin G., Freire M. B., Warram J. H., Krolewski A. S. Angiotensinogen polymorphism M235T, hypertension, and nephropathy in insulin-dependent diabetes. Hypertension. 1996 May;27(5):1134–1139. doi: 10.1161/01.hyp.27.5.1134. [DOI] [PubMed] [Google Scholar]
  18. Doria A., Warram J. H., Krolewski A. S. Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I--converting enzyme gene. Diabetes. 1994 May;43(5):690–695. doi: 10.2337/diab.43.5.690. [DOI] [PubMed] [Google Scholar]
  19. Dudley C. R., Keavney B., Stratton I. M., Turner R. C., Ratcliffe P. J. U.K. Prospective Diabetes Study. XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int. 1995 Dec;48(6):1907–1911. doi: 10.1038/ki.1995.490. [DOI] [PubMed] [Google Scholar]
  20. Earle K., Walker J., Hill C., Viberti G. Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. N Engl J Med. 1992 Mar 5;326(10):673–677. doi: 10.1056/NEJM199203053261005. [DOI] [PubMed] [Google Scholar]
  21. Erdös E. G. Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture. Hypertension. 1990 Oct;16(4):363–370. doi: 10.1161/01.hyp.16.4.363. [DOI] [PubMed] [Google Scholar]
  22. Fabiny D. L., Ertingshausen G. Automated reaction-rate method for determination of serum creatinine with the CentrifiChem. Clin Chem. 1971 Aug;17(8):696–700. [PubMed] [Google Scholar]
  23. Fogarty D. G., Harron J. C., Hughes A. E., Nevin N. C., Doherty C. C., Maxwell A. P. A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes. 1996 Sep;45(9):1204–1208. doi: 10.2337/diab.45.9.1204. [DOI] [PubMed] [Google Scholar]
  24. Gallois Y., Vol S., Cacès E., Balkau B. Distribution of fasting serum insulin measured by enzyme immunoassay in an unselected population of 4,032 individuals. Reference values according to age and sex. D.E.S.I.R. Study Group. Données Epidémiologiques sur le Syndrome d'Insulino-Résistance. Diabetes Metab. 1996 Dec;22(6):427–431. [PubMed] [Google Scholar]
  25. Hall J. E., Guyton A. C., Jackson T. E., Coleman T. G., Lohmeier T. E., Trippodo N. C. Control of glomerular filtration rate by renin-angiotensin system. Am J Physiol. 1977 Nov;233(5):F366–F372. doi: 10.1152/ajprenal.1977.233.5.F366. [DOI] [PubMed] [Google Scholar]
  26. Hallab M., Gallois Y., Chatellier G., Rohmer V., Fressinaud P., Marre M. Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes. BMJ. 1993 Jan 16;306(6871):175–182. doi: 10.1136/bmj.306.6871.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Hannedouche T., Landais P., Goldfarb B., el Esper N., Fournier A., Godin M., Durand D., Chanard J., Mignon F., Suo J. M. Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure. BMJ. 1994 Oct 1;309(6958):833–837. doi: 10.1136/bmj.309.6958.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Harden P. N., Geddes C., Rowe P. A., McIlroy J. H., Boulton-Jones M., Rodger R. S., Junor B. J., Briggs J. D., Connell J. M., Jardine A. G. Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet. 1995 Jun 17;345(8964):1540–1542. doi: 10.1016/s0140-6736(95)91088-3. [DOI] [PubMed] [Google Scholar]
  29. Hostetter T. H., Troy J. L., Brenner B. M. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int. 1981 Mar;19(3):410–415. doi: 10.1038/ki.1981.33. [DOI] [PubMed] [Google Scholar]
  30. Jaffa A. A., Rust P. F., Mayfield R. K. Kinin, a mediator of diabetes-induced glomerular hyperfiltration. Diabetes. 1995 Feb;44(2):156–160. doi: 10.2337/diab.44.2.156. [DOI] [PubMed] [Google Scholar]
  31. Jeunemaitre X., Soubrier F., Kotelevtsev Y. V., Lifton R. P., Williams C. S., Charru A., Hunt S. C., Hopkins P. N., Williams R. R., Lalouel J. M. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992 Oct 2;71(1):169–180. doi: 10.1016/0092-8674(92)90275-h. [DOI] [PubMed] [Google Scholar]
  32. Keavney B. D., Dudley C. R., Stratton I. M., Holman R. R., Matthews D. R., Ratcliffe P. J., Turner R. C. UK prospective diabetes study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM. Diabetologia. 1995 Aug;38(8):948–952. doi: 10.1007/BF00400584. [DOI] [PubMed] [Google Scholar]
  33. Kofoed-Enevoldsen A., Borch-Johnsen K., Kreiner S., Nerup J., Deckert T. Declining incidence of persistent proteinuria in type I (insulin-dependent) diabetic patients in Denmark. Diabetes. 1987 Feb;36(2):205–209. doi: 10.2337/diab.36.2.205. [DOI] [PubMed] [Google Scholar]
  34. Krolewski A. S., Warram J. H., Rand L. I., Kahn C. R. Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med. 1987 Nov 26;317(22):1390–1398. doi: 10.1056/NEJM198711263172206. [DOI] [PubMed] [Google Scholar]
  35. Lewis E. J., Hunsicker L. G., Bain R. P., Rohde R. D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med. 1993 Nov 11;329(20):1456–1462. doi: 10.1056/NEJM199311113292004. [DOI] [PubMed] [Google Scholar]
  36. Lieberman J., Sastre A. Serum angiotensin-converting enzyme: elevations in diabetes mellitus. Ann Intern Med. 1980 Dec;93(6):825–826. doi: 10.7326/0003-4819-93-6-825. [DOI] [PubMed] [Google Scholar]
  37. Ludwig E., Corneli P. S., Anderson J. L., Marshall H. W., Lalouel J. M., Ward R. H. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation. 1995 Apr 15;91(8):2120–2124. doi: 10.1161/01.cir.91.8.2120. [DOI] [PubMed] [Google Scholar]
  38. Marre M., Bernadet P., Gallois Y., Savagner F., Guyene T. T., Hallab M., Cambien F., Passa P., Alhenc-Gelas F. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes. 1994 Mar;43(3):384–388. doi: 10.2337/diab.43.3.384. [DOI] [PubMed] [Google Scholar]
  39. Marre M., Chatellier G., Leblanc H., Guyene T. T., Menard J., Passa P. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ. 1988 Oct 29;297(6656):1092–1095. doi: 10.1136/bmj.297.6656.1092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Marre M., Claudel J. P., Ciret P., Luis N., Suarez L., Passa P. Laser immunonephelometry for routine quantification of urinary albumin excretion. Clin Chem. 1987 Feb;33(2 Pt 1):209–213. [PubMed] [Google Scholar]
  41. Marre M., Leblanc H., Bruel D., Leroy M., Passa P. Relations entre excrétion urinaire d'albumine et rétinopathie chez les diabétiques insulino-dépendants. Presse Med. 1986 Sep 27;15(32):1621–1624. [PubMed] [Google Scholar]
  42. Marre M., Leblanc H., Suarez L., Guyenne T. T., Ménard J., Passa P. Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. Br Med J (Clin Res Ed) 1987 Jun 6;294(6585):1448–1452. doi: 10.1136/bmj.294.6585.1448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Maschio G., Alberti D., Janin G., Locatelli F., Mann J. F., Motolese M., Ponticelli C., Ritz E., Zucchelli P. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med. 1996 Apr 11;334(15):939–945. doi: 10.1056/NEJM199604113341502. [DOI] [PubMed] [Google Scholar]
  44. Mattu R. K., Needham E. W., Galton D. J., Frangos E., Clark A. J., Caulfield M. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation. 1995 Jan 15;91(2):270–274. doi: 10.1161/01.cir.91.2.270. [DOI] [PubMed] [Google Scholar]
  45. Mizuiri S., Hemmi H., Inoue A., Yoshikawa H., Tanegashima M., Fushimi T., Ishigami M., Amagasaki Y., Ohara T., Shimatake H. Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron. 1995;70(4):455–459. doi: 10.1159/000188645. [DOI] [PubMed] [Google Scholar]
  46. Nakai K., Itoh C., Miura Y., Hotta K., Musha T., Itoh T., Miyakawa T., Iwasaki R., Hiramori K. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation. 1994 Nov;90(5):2199–2202. doi: 10.1161/01.cir.90.5.2199. [DOI] [PubMed] [Google Scholar]
  47. Neels H. M., van Sande M. E., Scharpé S. L. Sensitive colorimetric assay for angiotensin converting enzyme in serum. Clin Chem. 1983 Jul;29(7):1399–1403. [PubMed] [Google Scholar]
  48. Parving H. H., Hommel E., Mathiesen E., Skøtt P., Edsberg B., Bahnsen M., Lauritzen M., Hougaard P., Lauritzen E. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J (Clin Res Ed) 1988 Jan 16;296(6616):156–160. doi: 10.1136/bmj.296.6616.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Pettitt D. J., Saad M. F., Bennett P. H., Nelson R. G., Knowler W. C. Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1990 Jul;33(7):438–443. doi: 10.1007/BF00404096. [DOI] [PubMed] [Google Scholar]
  50. Pirart J. Diabète et complications dégénératives présentation d'une étude prospective portant sur 4400 cas observés entre 1947 et 1973. (Première partie). Diabete Metab. 1977 Jun;3(2):97–107. [PubMed] [Google Scholar]
  51. Powrie J. K., Watts G. F., Ingham J. N., Taub N. A., Talmud P. J., Shaw K. M. Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes. BMJ. 1994 Dec 17;309(6969):1608–1612. doi: 10.1136/bmj.309.6969.1608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Quinn M., Angelico M. C., Warram J. H., Krolewski A. S. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia. 1996 Aug;39(8):940–945. doi: 10.1007/BF00403913. [DOI] [PubMed] [Google Scholar]
  53. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990 Oct;86(4):1343–1346. doi: 10.1172/JCI114844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Rigat B., Hubert C., Corvol P., Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 1992 Mar 25;20(6):1433–1433. doi: 10.1093/nar/20.6.1433-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Rossing P., Tarnow L., Nielsen F. S., Boelskifte S., Brenner B. M., Parving H. H. Short stature and diabetic nephropathy. BMJ. 1995 Feb 4;310(6975):296–297. doi: 10.1136/bmj.310.6975.296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Ruiz J., Blanché H., Cohen N., Velho G., Cambien F., Cohen D., Passa P., Froguel P. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3662–3665. doi: 10.1073/pnas.91.9.3662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Schmidt S., Schöne N., Ritz E. Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int. 1995 Apr;47(4):1176–1181. doi: 10.1038/ki.1995.167. [DOI] [PubMed] [Google Scholar]
  58. Seaquist E. R., Goetz F. C., Rich S., Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med. 1989 May 4;320(18):1161–1165. doi: 10.1056/NEJM198905043201801. [DOI] [PubMed] [Google Scholar]
  59. Shanmugam V., Sell K. W., Saha B. K. Mistyping ACE heterozygotes. PCR Methods Appl. 1993 Oct;3(2):120–121. doi: 10.1101/gr.3.2.120. [DOI] [PubMed] [Google Scholar]
  60. Tarnow L., Cambien F., Rossing P., Nielsen F. S., Hansen B. V., Lecerf L., Poirier O., Danilov S., Boelskifte S., Borch-Johnsen K. Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia. 1995 Jul;38(7):798–803. doi: 10.1007/s001250050355. [DOI] [PubMed] [Google Scholar]
  61. Tarnow L., Cambien F., Rossing P., Nielsen F. S., Hansen B. V., Lecerf L., Poirier O., Danilov S., Parving H. H. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes. 1995 May;44(5):489–494. doi: 10.2337/diab.44.5.489. [DOI] [PubMed] [Google Scholar]
  62. Tarnow L., Cambien F., Rossing P., Nielsen F. S., Hansen B. V., Ricard S., Poirier O., Parving H. H. Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy. Diabetes. 1996 Mar;45(3):367–369. doi: 10.2337/diab.45.3.367. [DOI] [PubMed] [Google Scholar]
  63. Viberti G. C., Keen H., Wiseman M. J. Raised arterial pressure in parents of proteinuric insulin dependent diabetics. Br Med J (Clin Res Ed) 1987 Aug 29;295(6597):515–517. doi: 10.1136/bmj.295.6597.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Williamson J. R., Chang K., Frangos M., Hasan K. S., Ido Y., Kawamura T., Nyengaard J. R., van den Enden M., Kilo C., Tilton R. G. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes. 1993 Jun;42(6):801–813. doi: 10.2337/diab.42.6.801. [DOI] [PubMed] [Google Scholar]
  65. Yoshida H., Mitarai T., Kawamura T., Kitajima T., Miyazaki Y., Nagasawa R., Kawaguchi Y., Kubo H., Ichikawa I., Sakai O. Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest. 1995 Nov;96(5):2162–2169. doi: 10.1172/JCI118270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. van Essen G. G., Rensma P. L., de Zeeuw D., Sluiter W. J., Scheffer H., Apperloo A. J., de Jong P. E. Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy. Lancet. 1996 Jan 13;347(8994):94–95. doi: 10.1016/s0140-6736(96)90213-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES